Author: pharmacybiz

Community pharmacists in Northern Ireland have sounded an alarm they may not be able to supply essential prescription medicines to patients in the coming weeks due to skyrocketing prices and... Read More

Following a comprehensive review, the Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that current evidence does not support a causal link between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and... Read More

As Know Your Numbers! Week (2-8 September) kicks off, the NHS England is encouraging people in the East Midlands to get their blood pressure checked to prevent heart attacks and... Read More

Police chiefs are reporting significant progress in their battle against shoplifting epidemic, thanks to the newly established centralised police unit – Operation Opal. Launched earlier this year, Operation Opal is the... Read More

Private equity firms HIG and Capvest have joined the list of investors who have expressed interest in acquiring AAH Pharmaceuticals – the biggest supplier of goods to British pharmacies. The company,... Read More

Rural areas have been hit the hardest by a wave of pharmacy closures over the past two years, according to a new analysis by the National Pharmacy Association (NPA). The analysis... Read More

Community Pharmacy England (CPE) has voiced concerns that pharmacy owners may find it challenging to achieve the increased Pharmacy First thresholds planned for September and October. Following initial representations by CPE,... Read More

Despite being the most common genetic disorder in the UK, sickle cell disease (SCD) remains significantly underfunded and underserved compared to other genetic disorders, according to a new report published... Read More

The National Pharmacy Association (NPA) will deliver the national #saveourpharmacies petition to Prime Minister Keir Starmer and Health Secretary Wes Streeting on September 19. Over 300,000 people have signed the cross-sector... Read More

The UK government has announced the launch of a new joint public-private investment programme aimed at accelerating patient access to cutting-edge treatments, enhancing clinical trials, and bolstering the country’s medicines... Read More